Skip to content
Bomb Report – Lifestyle
Author:
Vicore Pharma Holding
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market
July 1, 2026
Vicore Pharma to Host Webcast to Discuss Buloxibutid and the Evolving IPF Treatment Landscape
June 2, 2026
Vicore Pharma to Present at the Jefferies Global Healthcare Conference
May 26, 2026
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC
May 22, 2026
←
Previous Page
1
2